Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis
Dalila Martínez, Gustavo Heudebert, Carlos Seas et al. · 2010
Read Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis by Dalila Martínez, Gustavo Heudebert, Carlos Seas et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012082.txt.
Description
Dalila Martínez and co-workers built in 2010 a simple rule to sort tuberculosis patients by their risk of drug-resistant disease. Multidrug-resistant TB resists at least isoniazid and rifampin, the two best TB drugs, and confirming it takes time and lab capacity many clinics lack. A clinical prediction rule was developed and internally validated among adult patients with pulmonary TB.
The rule stratifies patients so that those likeliest to carry resistant disease get tested and treated accordingly first. In settings where drug-susceptibility testing cannot cover everyone, ranking risk is not a shortcut but a necessity. Used well, the rule speeds the right treatment to the patients whose wrong treatment would do the most harm.
Catalog record
| CREATOR | Dalila Martínez, Gustavo Heudebert, Carlos Seas et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012082